TrialDiabetes, obesity & metabolism2010

Improved glycaemic control with minimal hypoglycaemia and no weight change with the once-daily human glucagon-like peptide-1 analogue liraglutide as add-on to sulphonylurea in Japanese patients with type 2 diabetes.

K Kaku et al.PubMed ↗Publisher ↗

No numbers read from the abstract.